A versatile high-throughput assay based on 3D ring-shaped cardiac tissues generated from human induced pluripotent stem cell-derived cardiomyocytes.
cardiac myocytes
drug screening
heart
human
induced pluripotent stem cells
organoids
regenerative medicine
stem cells
tissue engineering
Journal
eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614
Informations de publication
Date de publication:
05 Apr 2024
05 Apr 2024
Historique:
medline:
5
4
2024
pubmed:
5
4
2024
entrez:
5
4
2024
Statut:
epublish
Résumé
We developed a 96-well plate assay which allows fast, reproducible, and high-throughput generation of 3D cardiac rings around a deformable optically transparent hydrogel (polyethylene glycol [PEG]) pillar of known stiffness. Human induced pluripotent stem cell-derived cardiomyocytes, mixed with normal human adult dermal fibroblasts in an optimized 3:1 ratio, self-organized to form ring-shaped cardiac constructs. Immunostaining showed that the fibroblasts form a basal layer in contact with the glass, stabilizing the muscular fiber above. Tissues started contracting around the pillar at D1 and their fractional shortening increased until D7, reaching a plateau at 25±1%, that was maintained up to 14 days. The average stress, calculated from the compaction of the central pillar during contractions, was 1.4±0.4 mN/mm
Identifiants
pubmed: 38578976
doi: 10.7554/eLife.87739
pii: 87739
doi:
pii:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Leducq Foundation
ID : 18CVD05
Informations de copyright
© 2023, Seguret et al.
Déclaration de conflit d'intérêts
MS, CJ, CP, QL, LD, ML, JH No competing interests declared, PD, SR, CC, RR Employee of 4Dcell, which manufactured the 3D gel structures